Sign in

CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company

Eledon Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
949-238-8090
Business address
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
Former names
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-05-03 Smith Bryan E. See Remarks Grant or award · Stock Option (Right to Buy) +158,500 158,500
2020-12-22 BVF PARTNERS L P/IL See Explanation of Responses Conversion +15,166 117,565
2020-12-22 BVF PARTNERS L P/IL See Explanation of Responses Conversion +654,215 771,780
2020-12-22 BVF PARTNERS L P/IL See Explanation of Responses Conversion +11,278 89,214
2020-12-22 BVF PARTNERS L P/IL See Explanation of Responses Conversion +509,410 598,624
2020-12-22 BVF PARTNERS L P/IL See Explanation of Responses Conversion +1,944 15,537
2020-12-22 BVF PARTNERS L P/IL See Explanation of Responses Conversion +97,615 113,152
2020-12-22 BVF PARTNERS L P/IL See Explanation of Responses Conversion · Series X Convertible Preferred −273 0
2020-12-22 BVF PARTNERS L P/IL See Explanation of Responses Conversion · Series X Convertible Preferred −203 0
2020-12-22 BVF PARTNERS L P/IL See Explanation of Responses Conversion · Series X Convertible Preferred −35 0
2020-12-22 BVF PARTNERS L P/IL See Explanation of Responses Conversion · Series X1 Convertible Preferred Stock −11,776 52,145
2020-12-22 BVF PARTNERS L P/IL See Explanation of Responses Conversion · Series X1 Convertible Preferred Stock −9,169 39,693
2020-12-22 BVF PARTNERS L P/IL See Explanation of Responses Conversion · Series X1 Convertible Preferred Stock −1,757 6,758
2020-12-02 OrbiMed Israel GP Ltd. 10% owner Sale −103,200 $21.60 $2.2M 73,650
2020-10-30 Logos Global Management LP 10% owner Purchase +5,000 $24.03 $120K 150,000
2020-10-30 Logos Global Management LP 10% owner Purchase +31,000 $24.53 $760K 181,000
2020-10-30 Logos Global Management LP 10% owner Purchase +4,000 $25.97 $104K 185,000
2020-10-30 Logos Global Management LP 10% owner Purchase +15,000 $26.48 $397K 200,000
2020-10-30 Logos Global Management LP 10% owner Sale −12,942 $26.64 $345K 187,058
2020-10-30 Logos Global Management LP 10% owner Purchase +12,942 $25.88 $335K 200,000

Page 6 of 15 · 300 trades